Related references
Note: Only part of the references are listed.Long-Term Inhaled Dry Powder Mannitol in Cystic Fibrosis An International Randomized Study
Moira L. Aitken et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2012)
Oxidative stress and antioxidant therapy in cystic fibrosis
Francesco Galli et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2012)
Innate immunity in cystic fibrosis lung disease
D. Hartl et al.
JOURNAL OF CYSTIC FIBROSIS (2012)
Contribution by Polymorphonucleate Granulocytes to Elevated Gamma-Glutamyltransferase in Cystic Fibrosis Sputum
Alessandro Corti et al.
PLOS ONE (2012)
Infection, Inflammation, and Lung Function Decline in Infants with Cystic Fibrosis
Naveen Pillarisetti et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Denufosol Tetrasodium in Patients with Cystic Fibrosis and Normal to Mildly Impaired Lung Function
Frank J. Accurso et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Accurate Assessment of Adherence Self-Report and Clinician Report vs Electronic Monitoring of Nebulizers
Tracey Daniels et al.
CHEST (2011)
356* Use of patient monitoring systems in clinical trials to generate objective information on patients' drug adherence of inhaled medications
C. Fuchs et al.
Journal of Cystic Fibrosis (2011)
Novel Method to Process Cystic Fibrosis Sputum for Determination of Oxidative State
A. Hector et al.
RESPIRATION (2010)
Hypertonic saline increases lung epithelial lining fluid glutathione and thiocyanate: two protective CFTR-dependent thiols against oxidative injury
Neal S. Gould et al.
RESPIRATORY RESEARCH (2010)
Cystic Fibrosis: Evolution from a Fatal Disease of Infancy with a Clear Phenotype to a Chronic Disease of Adulthood with Diverse Manifestations
Clement L. Ren
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2008)
Improvement in clinical markers in CF patients using a reduced glutathione regimen: An uncontrolled, observational study
Alfredo Visca et al.
JOURNAL OF CYSTIC FIBROSIS (2008)
Antioxidants in cystic fibrosis - Conclusions from the CF antioxidant workshop, Bethesda, Maryland, November 11-12, 2003
Andre M. Cantin et al.
FREE RADICAL BIOLOGY AND MEDICINE (2007)
A controlled trial of long-term inhaled hypertonic saline in patients with cystic fibrosis
MR Elkins et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
A pilot study of the effect of inhaled buffered reduced glutathione on the clinical status of patients with cystic fibrosis
C Bishop et al.
CHEST (2005)
Improvement of alveolar glutathione and lung function but not oxidative state in cystic fibrosis
M Griese et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2004)
The revised German Cystic Fibrosis Questionnaire: Validation of a disease-specific health-related quality of life instrument
K Wenninger et al.
QUALITY OF LIFE RESEARCH (2003)
Comparison of hypertonic saline and alternate-day or daily recombinant human deoxyribonuclease in children with cystic fibrosis: a randomised trial
R Suri et al.
LANCET (2001)
Rethinking cystic fibrosis pathology: The critical role of abnormal reduced glutathione (GSH) transport caused by CFTR mutation
VM Hudson
FREE RADICAL BIOLOGY AND MEDICINE (2001)
Share Paper
